On Thursday 14 August, Dr Joaquín Arribas, Director of the Hospital del Mar Research Institute (HMRIB), and Dr Vanesa Nogales, its General Manager, visited the Josep Carreras Leukaemia Research Institute. They were received by the new Director of the IJC, Dr Ari Melnick, the incoming Managing Director, Cristina Casaus, and accompanied by Dr Anna Bigas, Principal Investigator of the Stem cells and cancer group, who is affiliated with both institutions.

The institutional meeting provided an opportunity to share strategic challenges as well as to identify and explore new areas of collaboration. Within this framework, the leadership of both centres formalised the agreement regarding the cell culture room at the HMRIB facilities. This initiative, promoted by the IJC and the Josep Carreras Foundation, provides researchers with a state-of-the-art infrastructure to carry out their research.

For Dr Melnick, Director of the IJC, this agreement is “a prominent example of inter-institutional synergy and of both institutions’ commitment to interactive and collaborative science.”

Dr Arribas, director of the HMRIB, emphasises that “with this alliance, we are strengthening our already excellent collaboration with the IJC, which reaffirms our commitment to translational research in haematological tumours.”

With this agreement, the HMRIB and the Josep Carreras Institute reaffirm their commitment to continue working together to push the boundaries of medicine, with a particular focus on eradicating leukaemia and other haematological diseases through clinical and translational research and outstanding scientific cooperation.